Multiple Sclerosis Clinical Trials

Showing 3641-3660 of 5,960 trials

Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy

NCT03879486

The main purpose of this study is to compare the infectious outcomes of intrarectal povidone-iodine cleansing plus formalin disinfection of needle tip during transrectal ultrasound guided prostate biopsy. The secondary objective is to evaluate predictive factors of infectious complications after prostate biopsy. Data will be prospectively collected from patients who will undergo prostate biopsy in a single high volume urology center. The patients will be randomized to two different groups: group A - rectal cleansing and disinfection of the needle tip vs group B - controls.

Prostate CancerProstatic NeoplasmsProstate Biopsy+1 more

Hospital de Transplante Doutor Euryclides de Jesus Zerbini1,257 participantsStarted May 2017

São Paulo, Brazil

COMPLETEDPhase 4

A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes

NCT01930708

The primary objective of the study is to estimate the annualized relapse rate (ARR) in participants with Relapsing Remitting Multiple Sclerosis (RRMS) who are treated with dimethyl fumarate (DMF) over a 12-month period. The secondary objectives of this study in this population are to assess the impact of DMF over a 12-month period on participants -reported health-related quality of life (HRQoL) outcomes, additional clinical effectiveness outcomes, and health economics-related outcomes, and to characterize participants-reported adherence to DMF.

Relapsing-Remitting Multiple SclerosisMultiple Sclerosis

Biogen1,114 participantsStarted Oct 2013

Innsbruck, Austria • Klagenfurt, Austria • Linz, Austria +87 more locations

Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy

A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes

Related Searches

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

Magnetic Occult Lesion Localization and Imaging (MOLLI)

Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Exercise to Manage Fatigue in Progressive Multiple Sclerosis

Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent

Integrative Medicine on Exam Anxiety

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

The Impact of Unilateral Lumbar Mobilisations on Hamstring Strength and Failure Point of the Hamstring Nordic Exercise

MicroRNA-150 and microRNA-155 in Multiple Sclerosis

Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine

Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study

Intrathecal Mafosfamide

Screening of Colorectal Cancer in the Public Healthcare Sector in Argentina

A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer

Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B